CFO
TECH icon

CVA Family Office’s Bio-Techne TECH Stock Holding History

CVA Family Office’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Buy
196
+13
+7% +$702 ﹤0.01% 927
2026
Q1 		$9.56K Buy
183
+7
+4% +$420 ﹤0.01% 1005
2025
Q4 		$10.4K Hold
176
– – ﹤0.01% 789
2025
Q3 		$9.79K Buy
176
+126
+252% +$6.75K ﹤0.01% 809
2025
Q2 		$2.57K Sell
50
-233
-82% -$11.7K ﹤0.01% 961
2025
Q1 		$16.6K Sell
283
-131
-32% -$8.88K ﹤0.01% 713
2024
Q4 		$29.8K Buy
414
+7
+2% +$514 ﹤0.01% 609
2024
Q3 		$32.5K Hold
407
– – 0.01% 579
2024
Q2 		$29.2K Buy
407
+7
+2% +$515 0.01% 587
2024
Q1 		$28.2K Hold
400
– – 0.01% 586
2023
Q4 		$30.9K Buy
+400
New +$26.3K 0.01% 554
2023
Q3 		– Sell
-180
Closed -$14.7K – 864
2023
Q2 		$14.7K Buy
+180
New +$14.5K ﹤0.01% 668
2023
Q1 		– Sell
-5
Closed -$414 – 1006
2022
Q4 		$414 Sell
5
-35
-88% -$2.78K ﹤0.01% 909
2022
Q3 		$3K Hold
40
– – ﹤0.01% 793
2022
Q2 		$3K Hold
40
– – ﹤0.01% 810
2022
Q1 		$4K Buy
+40
New +$4.13K ﹤0.01% 812
2021
Q3 		– Sell
-56
Closed -$6K – 826
2021
Q2 		$6K Buy
+56
New +$5.89K ﹤0.01% 744

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CVA Family Office's TECH Position: Q2 2026 in Review

CVA Family Office increased its Bio-Techne (TECH) stake by 7.1% in Q2 2026, buying an estimated $702 and bringing the position to 196 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #927.

CVA Family Office first reported a position in TECH in Q2 2021 and has held it in 17 quarters since. The position peaked at $32.5K in Q3 2024. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • CVA Family Office held 196 shares of Bio-Techne worth $13.8K as of Q2 2026.
  • CVA Family Office bought 13 Bio-Techne shares in Q2 2026, an estimated $702.
  • Bio-Techne made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #927 holding.
  • CVA Family Office first reported a position in Bio-Techne in Q2 2021 and has held it in 17 quarters since.
  • CVA Family Office's Bio-Techne position peaked at $32.5K in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.